Cargando…

Recurrent Erythema Multiforme Major Following COVID-19 Infection

Erythema multiforme (EM) is a rare and potentially serious skin condition that can present as a myriad of mucocutaneous lesions. EM can be commonly confused with other cutaneous etiologies, leading to misdiagnosis and delay in proper treatment. This paper describes a case of recurrent erythema multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rykiel, Kayla, Melchor, Julian, Motie, Ian, Mulles, Kevin, Farhangi, Vida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461501/
https://www.ncbi.nlm.nih.gov/pubmed/37644930
http://dx.doi.org/10.7759/cureus.42646
_version_ 1785097852535439360
author Rykiel, Kayla
Melchor, Julian
Motie, Ian
Mulles, Kevin
Farhangi, Vida
author_facet Rykiel, Kayla
Melchor, Julian
Motie, Ian
Mulles, Kevin
Farhangi, Vida
author_sort Rykiel, Kayla
collection PubMed
description Erythema multiforme (EM) is a rare and potentially serious skin condition that can present as a myriad of mucocutaneous lesions. EM can be commonly confused with other cutaneous etiologies, leading to misdiagnosis and delay in proper treatment. This paper describes a case of recurrent erythema multiforme following COVID-19 infection in a 34-year-old male with no prior medical history. The patient had an extensive rash of the oral and genital mucosal areas, diffuse cutaneous involvement, and an extended length of recovery. This unexpected association of EM and COVID-19 provides additional insight into the limited research available regarding the correlation between these two pathologies.
format Online
Article
Text
id pubmed-10461501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104615012023-08-29 Recurrent Erythema Multiforme Major Following COVID-19 Infection Rykiel, Kayla Melchor, Julian Motie, Ian Mulles, Kevin Farhangi, Vida Cureus Dermatology Erythema multiforme (EM) is a rare and potentially serious skin condition that can present as a myriad of mucocutaneous lesions. EM can be commonly confused with other cutaneous etiologies, leading to misdiagnosis and delay in proper treatment. This paper describes a case of recurrent erythema multiforme following COVID-19 infection in a 34-year-old male with no prior medical history. The patient had an extensive rash of the oral and genital mucosal areas, diffuse cutaneous involvement, and an extended length of recovery. This unexpected association of EM and COVID-19 provides additional insight into the limited research available regarding the correlation between these two pathologies. Cureus 2023-07-29 /pmc/articles/PMC10461501/ /pubmed/37644930 http://dx.doi.org/10.7759/cureus.42646 Text en Copyright © 2023, Rykiel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Rykiel, Kayla
Melchor, Julian
Motie, Ian
Mulles, Kevin
Farhangi, Vida
Recurrent Erythema Multiforme Major Following COVID-19 Infection
title Recurrent Erythema Multiforme Major Following COVID-19 Infection
title_full Recurrent Erythema Multiforme Major Following COVID-19 Infection
title_fullStr Recurrent Erythema Multiforme Major Following COVID-19 Infection
title_full_unstemmed Recurrent Erythema Multiforme Major Following COVID-19 Infection
title_short Recurrent Erythema Multiforme Major Following COVID-19 Infection
title_sort recurrent erythema multiforme major following covid-19 infection
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461501/
https://www.ncbi.nlm.nih.gov/pubmed/37644930
http://dx.doi.org/10.7759/cureus.42646
work_keys_str_mv AT rykielkayla recurrenterythemamultiformemajorfollowingcovid19infection
AT melchorjulian recurrenterythemamultiformemajorfollowingcovid19infection
AT motieian recurrenterythemamultiformemajorfollowingcovid19infection
AT mulleskevin recurrenterythemamultiformemajorfollowingcovid19infection
AT farhangivida recurrenterythemamultiformemajorfollowingcovid19infection